Stock Research: Mesa Laboratories

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Mesa Laboratories

NasdaqGS:MLAB US59064R1095
20
  • Value
    9
  • Growth
    33
  • Safety
    Safety
    82
  • Combined
    24
  • Sentiment
    23
  • 360° View
    360° View
    20
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions. It operates in the pharmaceutical, healthcare, and medical device industries. The company operates globally. In the last fiscal year, the company had a market cap of $431 million, profits of $151 million, revenue of $241 million, and 730 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 20 (better than 20% compared with alternatives), overall professional sentiment and financial characteristics for the stock Mesa Laboratories are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Mesa Laboratories. Only the consolidated Value Rank has an attractive rank of 82, which means that the share price of Mesa Laboratories is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 82% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 33, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 9, meaning the company has a riskier financing structure than 91% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 77% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 23. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
82 75 81 63
Growth
33 49 41 91
Safety
Safety
9 4 13 61
Sentiment
23 31 28 1
360° View
360° View
20 28 15 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
36 29 28 16
Opinions Change
50 50 50 13
Pro Holdings
n/a 54 32 45
Market Pulse
13 31 13 16
Sentiment
23 31 28 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
82 75 81 63
Growth
33 49 41 91
Safety Safety
9 4 13 61
Combined
24 34 28 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
23 54 10 14
Price vs. Earnings (P/E)
67 50 59 31
Price vs. Book (P/B)
67 41 85 65
Dividend Yield
88 86 89 88
Value
82 75 81 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
21 26 44 43
Profit Growth
100 83 89 100
Capital Growth
23 4 17 73
Stock Returns
15 87 29 67
Growth
33 49 41 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
26 19 34 47
Refinancing
3 1 25 53
Liquidity
56 61 61 63
Safety Safety
9 4 13 61

Similar Stocks

Discover high‑ranked alternatives to Mesa Laboratories and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.